Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Arcutis Biotherapeutics Inc. (ARQT)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1. 10,542,790 $314,175 35.62%
2.
Vivo Capital

Albert Cha And Frank Kung

1,686,527 $50,259 4.55%
3.
OrbiMed Advisors

Samuel Isaly

4,673,850 $139,281 2.34%
4.
RA Capital Management

Peter Kolchinsky

1,165,184 $34,722 1.09%
5.
Polar Capital

Brian Ashford-Russell And Tim Woolley

375,000 $11,175 0.12%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$17.00 294,117 Large Shareholder 3,979,292 2020-02-04 Filing
$17.00 500,000 Large Shareholder, Director 10,542,790 2020-02-04 Filing
$17.00 500,000 Large Shareholder 10,542,790 2020-02-04 Filing
$17.00 176,500 Large Shareholder, Director 176,500 2020-02-03 Filing
$17.00 382,388 Large Shareholder, Director 382,388 2020-02-03 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 3,979,292 $118,583 20.05%
2. 844,680 $25,171 10.41%
3. 22,413 $668 0.06%
4. 5,713,343 $170,258 0.02%
5. 6,159 $184 0%